Related Experiment Video
Updated: Jun 28, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
[Genes and epilepsy II: differential gene expression in epilepsy]
Rodrigo N Romcy-Pereira1, Daniel L G Gitaí, Lívia L G Gitaí
1Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, SP. rnrpereira@rnp.fmrp.usp.br
Revista Da Associacao Medica Brasileira (1992)
|November 8, 2008
Summary
Investigating gene expression in epilepsy reveals molecular changes linked to distinct psychopathological stages. Understanding these patterns is key for developing new epilepsy treatments targeting neurotoxicity and synaptic dysfunction.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Context:
- Epilepsy is a complex neurological disorder characterized by recurrent seizures.
- Molecular alterations in the brain are implicated in epilepsy's progression.
- Investigating gene expression provides insights into epilepsy's underlying mechanisms.
Purpose:
- To explore differential gene expression in human epilepsy and animal models.
- To correlate molecular alterations with psychopathological stages of epilepsy.
- To identify gene expression patterns related to neuronal and glial functions.
Summary:
- Differential gene expression analysis in human and animal epilepsy models reveals molecular changes.
- These alterations involve pathways such as cell death, oxidative stress, synaptic transmission, immune response, and neurotrophins.
- Gene expression patterns may reflect distinct functional states of neuronal and glial cells, influencing brain region-specific responses.
Impact:
- Understanding epilepsy-related gene expression is crucial for developing targeted therapies.
- Insights can guide the development of treatments to reduce neurotoxicity in epilepsy.
- Identifying molecular patterns aids in addressing synaptic dysfunctions in both early and chronic epilepsy phases.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...